Delivery Order SPE2DB22D9353-SPE2DB23FX2JV
Award Date 9/11/23
Potential Completion Date 10/2/23
Potential Value $79K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $52,702 delivery order to DMS Pharmaceutical Group Inc. to supply 3,750 units of the pharmaceutical product ASPARLAS 3,750 UNIT/5 ML VIAL 5ML. The firm fixed price order is being carried out under the prime contractor's Park Ridge, Illinois operations, with performance required between September 25 and October 17, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the Department of Defense's global...
- The Defense Logistics Agency awarded a delivery order valued at $81,462.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas (5 ML vials). The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 15, 2026. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 3,750 units of Asparlas (5 mL vials) with a ceiling value of $19,695.92. This firm fixed-price delivery order, awarded on October 22, 2025, with an ultimate completion date of November 13, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $40.7K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 mL vials). This delivery order was issued under a firm fixed-price contract structure with an ultimate completion date of December 31, 2025, and represents no set-aside designation, indicating the vendor competed on an unrestricted basis. DMS Pharmaceutical Group was selected...
- The Defense Logistics Agency awarded a delivery order valued at $61,096.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 ML vials). This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 milliliter vials. This firm fixed-price delivery order is expected to reach completion by August 29, 2025, and represents a continuation of the companies' ongoing pharmaceutical supply relationship. The award carries no set-aside designation, indicating that DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a $55,229.58 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the 5 ML vial pharmaceutical product ASPARLAS. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract #SPE2DB22D9367 with DLA, which has a ceiling value of up to $4,999,999 and enables DLA to order a broad...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,614.78 fixed-price contract is for the delivery of 3,750 units of the drug Asparlas (5 mL vials) with a performance period through May 13, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the agency to...
- The Defense Logistics Agency awarded a delivery order valued at $118,467.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 ml vials. The contract is firm fixed-price with an ultimate completion date of September 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle that...
- The Defense Logistics Agency awarded a $148,084.30 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 17, 2025. The delivery order calls for 3,750 units of Asparlas (5 ML vials) with a completion date of August 7, 2025. This firm fixed-price contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The award...